Akzo Nobel N V ADR (AKZOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 4,034,688 | 4,227,132 | 4,009,950 | 3,921,860 | 3,704,010 |
| Cost of Goods | 2,174,470 | 3,492,880 | 3,605,940 | 0 | 8,733,000 |
| Gross Profit | 3,175,040 | 402,360 | 404,010 | 3,919,360 | -3,351,860 |
| Operating Expenses | 3,106,620 | 880 | 44,350 | 3,554,650 | -3,993,480 |
| Operating Income | -1,245,932 | 734,252 | 360,600 | 367,210 | -1,035,510 |
| Interest Expense | 192,200 | 0 | 0 | 0 | 232,000 |
| Other Income | 1,976,602 | -364,912 | -10 | -42,470 | 1,794,810 |
| Pre-tax Income | 538,470 | 369,340 | 360,590 | 324,740 | 527,300 |
| Income Tax | 95,660 | 106,400 | 98,890 | 102,410 | 310,910 |
| Net Income Continuous | 119,448 | 691,471 | 135,072 | 166,117 | 319,188 |
| Net Income | $119,448 | $691,471 | $135,072 | $166,117 | $319,188 |
| EPS Basic Total Ops | 0.15 | 0.91 | 0.18 | 0.22 | 0.42 |
| EPS Basic Continuous Ops | 0.15 | 0.91 | 0.18 | 0.22 | 0.42 |
| EPS Diluted Total Ops | 0.15 | 0.91 | 0.18 | 0.22 | 0.42 |
| EPS Diluted Continuous Ops | 0.15 | 0.91 | 0.18 | 0.22 | 0.42 |
| EBITDA(a) | $-903,232 | $918,112 | $736,870 | $367,210 | $-40,510 |